Serious safety issues have arisen after 11 people died during trials for the bird flu vaccine AUDENZ™, which was promoted as “safe and effective” by the FDA. These deaths, reportedly covered up by mainstream media, have raised doubts about whether lessons from the contentious COVID-19 vaccine rollout are being learned. With increasing alarm regarding a potential bird flu pandemic, pharmaceutical companies and health authorities are fast-tracking H5N1 vaccine development, which has sparked further safety concerns.
Dr. Leana Wen, a public health advocate, has urged the Biden administration to speed up vaccine authorization to strengthen national defenses. She emphasized that delays could leave the country unprepared for serious risks. Critics, however, argue that the hurried development of AUDENZ™ reflects the same errors made during the COVID-19 vaccine launch, where lack of transparency in safety testing led to a loss of public trust and an increase in adverse events.
The UK has ordered five million doses of the AUDENZ™ vaccine as part of their pandemic readiness strategy, with other countries expected to follow. However, the trial’s results are concerning, as, besides the 11 deaths, participants also showed increased troponin T levels, indicating possible heart damage. Moreover, the trial's limited monitoring period of just a few weeks raises questions about the long-term safety and effectiveness of the vaccine.
Dr. Richard Bartlett criticized the short observation period, stating it is insufficient for assessing long-term effects. He also highlighted that AUDENZ™ only provides protection against the specific H5N1 subtype, raising issues if the virus mutates. Dr. Bartlett insisted that the public deserves comprehensive information before significant vaccine distribution begins.
The current push for bird flu vaccines has brought back memories of the rapid COVID-19 vaccine rollout, which many believe prioritized speed over safety. Adverse events reported during that period, including myocarditis and blood clots, have fueled skepticism towards health authorities. Dr. Bartlett remarked that the mistakes from the COVID-19 vaccine rollout should have taught that rushing safety protocols leads to severe consequences.
While pandemic preparedness is vital, it cannot compromise rigorous safety measures or ethical practices. Critics argue that elite global players and pharmaceutical companies exploit public fear, fueled by continuous media alarmism, to forward their agendas, coercing the public to accept hastily developed vaccines with little transparency.
Dr. Wen's urgent call to action coincides with increasing pressure on the Biden administration from pharmaceutical companies. However, a change in administration could impact vaccine policies, especially with the expected scrutinization under a potential Trump administration and figures like Robert F. Kennedy Jr. being placed in significant health roles.
Comments
Post a Comment